Point-of-care testing for COVID-19 using SHERLOCK diagnostics

1 Howard Hughes Medical Institute; Broad Institute of MIT and Harvard; McGovern Institute for Brain Research at MIT; Department of Biological Engineering at MIT;

1 Howard Hughes Medical Institute; Broad Institute of MIT and Harvard; McGovern Institute for Brain Research at MIT; Department of Biological Engineering at MIT;

2 Howard Hughes Medical Institute; Broad Institute of MIT and Harvard; McGovern Institute for Brain Research at MIT; Departments of Biological Engineering and Brain and Cognitive Sciences at MIT;

2 Howard Hughes Medical Institute; Broad Institute of MIT and Harvard; McGovern Institute for Brain Research at MIT; Departments of Biological Engineering and Brain and Cognitive Sciences at MIT;

3 University of Washington, Seattle;

3 University of Washington, Seattle;

3 University of Washington, Seattle;

4 Ragon Institute of MGH, MIT and Harvard; Massachusetts General Hospital; Massachusetts Consortium for Pathogen Readiness;

5 Ragon Institute of MGH, MIT and Harvard; Brigham and Women's Hospital; Massachusetts Consortium for Pathogen Readiness;

6 Howard Hughes Medical Institute; Massachusetts Consortium for Pathogen Readiness;

7 University of Washington, Seattle; Fred Hutchinson Cancer Research Center;

7 University of Washington, Seattle; Fred Hutchinson Cancer Research Center;

8 McGovern Institute for Brain Research at MIT; Massachusetts Consortium for Pathogen Readiness;

8 McGovern Institute for Brain Research at MIT; Massachusetts Consortium for Pathogen Readiness;

9 Howard Hughes Medical Institute; Broad Institute of MIT and Harvard; McGovern Institute for Brain Research at MIT; Departments of Biological Engineering and Brain and Cognitive Sciences at MIT; Massachusetts Consortium for Pathogen Readiness